GLP-1 Agonists
Sort by:
Canadian Collaborative Research Network
CV Medicine in the Next Decade: Predicting the Future
FEATURING
Deepak Bhatt
- 363 views
- June 13, 2022
- 2
Canadian Collaborative Research Network
GLP-1 Agonists: Underused and Underappreciated?
FEATURING
Darren K. Mcguire
- 315 views
- June 13, 2022
- 1
Canadian Collaborative Research Network
Q&A: Colchicine, Oral GLP-1a and Other Drugs
- 81 views
- June 13, 2022
Scripps Health
Diabetes Treatment 2022 and Cardiovascular Risk
FEATURING
Samantha Harris
- 679 views
- June 1, 2022
- 3
Cedars Sinai
New Approaches and Therapies for Weight Management and CVD Risk
FEATURING
Simona Campa
- 219 views
- May 25, 2022
- 3
ACC 2022 Conference Coverage
ACC 2022: An Overview of SGLT2i and GLP1 RA Use in Cardiovascular Disease
FEATURING
Robert Eckel
- 1,561 views
- May 24, 2022
- 9
Juan Frias
SUSTAIN FORTE: Once Weekly Semaglutide 2.0 mg in Patients With T2D
- 1,331 views
- April 11, 2022
- 8
13th Orange County Symposium for Cardiovascular Disease Prevention
SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Which Do I Choose?
FEATURING
Yehuda Handelsman
- 3,406 views
- January 27, 2022
- 15
Piedmont Heart Institute
Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i
FEATURING
Jaime Burkle
- 1,738 views
- January 25, 2022
- 18
KDIGO
SGLT2 Inhibitors and GLP-1 Receptor Agonists: Different Classes, Different Modes of Kidney Protection
FEATURING
Hiddo Lambers Heerspink
- 542 views
- January 24, 2022
- 6
16th Annual Mid-Atlantic Hospital Medicine Symposium
Peri-Operative Medication Management: Anticoagulants, DM & Steroids
FEATURING
Dennis Chang
- 521 views
- December 15, 2021
- 2
Houston Methodist Hospital
Non Alcoholic Fatty Liver Disease (NAFLD): What’s New and Impact of the COVID-19 Pandemic on Disease Burden
FEATURING
Victor Ankoma-Sey
- 548 views
- December 10, 2021
- 5
Practical Ways to Achieve Targets in Diabetes Care
Process for FDA Drug Approval
FEATURING
Mahtab Niyyati
- 13 views
- November 22, 2021
Practical Ways to Achieve Targets in Diabetes Care
Innovation and FDA's Role
FEATURING
Courtney Lias
- 31 views
- November 22, 2021
The Texas Heart Institute
Update of Diabetes Treatment: Overview of Current Trials and ADA Practice Recommendations
FEATURING
David Aguilar
- 776 views
- November 11, 2021
- 6
Houston Methodist DeBakey Heart and Vascular Center
Medical Management of Obesity: The Future Is Bright
FEATURING
Mohamad Taha
- 696 views
- October 20, 2021
- 4
Houston Methodist DeBakey Heart and Vascular Center
Cardiovascular and Renal Outcomes With Efpeglenatide in Type 2 Diabetes: AMPLITUDE-O Trial
FEATURING
Ildiko Lingvay
- 100 views
- October 20, 2021
Houston Methodist DeBakey Heart and Vascular Center
Practical Tips for Managing CVD Risk Among High-Risk Diabetes
FEATURING
Michael Blaha
- 507 views
- October 18, 2021
- 5
Houston Methodist DeBakey Heart and Vascular Center
Q&A: CVD Prevention in Diabetes
- 320 views
- October 11, 2021
Scripps Health
Kidney Disease Management: Diagnosis, CKD Indicators, Key Management Elements, KDIGO Guidelines and Pharmacological Options
FEATURING
Andrew J. King
- 1,374 views
- August 25, 2021
- 8
Scripps Health
Cost-Effective Diabetes Care: Strategies for T2D Management
FEATURING
Matthew J. Levine
- 1,295 views
- August 25, 2021
- 3